Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Medication use in pregnancy among people with disabilities: Impact on perinatal health

EF 2022-23

Résumé
One in eight females of reproductive age in Canada identify as having a physical, sensory or intellectual disability. Pregnancy rates among people with disabilities have increased over the past two decades in Ontario. People with disabilities are more likely than those without to experience health disparities, including adverse perinatal health outcomes. A common concern among people with disabilities is the use of multiple medicines to manage symptoms and complications of disability, and overprescribing, among which, opioids are commonly prescribed. Prenatal medication use can have adverse effects on perinatal health; however, little is known about medication use in pregnancy among people with disabilities in Canada. Our aim is to describe the prevalence and patterns of medication use in pregnancy among people with disabilities overall, and by disability group and medication type, and determine the impact of disability and medication use on perinatal health. We will use information from linked health care records for all birthing parent-infant pairs in Ontario from 2014-2021. In our analyses, we will estimate the prevalence and describe medication use patterns, including opioid, psychotropic, anticonvulsant and antibacterial use, before and in pregnancy among people with and without disabilities. We will follow a subgroup of people with opioid use in pregnancy and 12 months postpartum to determine whether people with disabilities compared to those without are at an increased risk of opioid dependence or overdose. Finally, we will determine whether prenatal medication use partly explains the elevated risk of adverse birth outcomes among people with disabilities compared to those without disabilities. Our findings will provide new information to create tailored preconception and perinatal health care for pregnant people with disabilities and will inform the development of accessible and inclusive medication management counselling.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
472052
Name
Camden Andi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Medication use in pregnancy among people with disabilities: Impact on perinatal health
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Epidemiology; Infant Health; Maternal Disability; Maternal Health; Perinatal Health; Population Health; Pregnancy/Birth; Prenatal Medication Use
Abstract
One in eight females of reproductive age in Canada identify as having a physical, sensory or intellectual disability. Pregnancy rates among people with disabilities have increased over the past two decades in Ontario. People with disabilities are more likely than those without to experience health disparities, including adverse perinatal health outcomes. A common concern among people with disabilities is the use of multiple medicines to manage symptoms and complications of disability, and overprescribing, among which, opioids are commonly prescribed. Prenatal medication use can have adverse effects on perinatal health; however, little is known about medication use in pregnancy among people with disabilities in Canada. Our aim is to describe the prevalence and patterns of medication use in pregnancy among people with disabilities overall, and by disability group and medication type, and determine the impact of disability and medication use on perinatal health. We will use information from linked health care records for all birthing parent-infant pairs in Ontario from 2014-2021. In our analyses, we will estimate the prevalence and describe medication use patterns, including opioid, psychotropic, anticonvulsant and antibacterial use, before and in pregnancy among people with and without disabilities. We will follow a subgroup of people with opioid use in pregnancy and 12 months postpartum to determine whether people with disabilities compared to those without are at an increased risk of opioid dependence or overdose. Finally, we will determine whether prenatal medication use partly explains the elevated risk of adverse birth outcomes among people with disabilities compared to those without disabilities. Our findings will provide new information to create tailored preconception and perinatal health care for pregnant people with disabilities and will inform the development of accessible and inclusive medication management counselling.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Camden, Andi
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~